✦ LIBER ✦

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

✍ Scribed by Del Re, Marzia; Ulivi, Paola; Passardi, Alessandro; Zoli, Wainer; Danesi, Romano; Amadori, Dino

Book ID: 125404153
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 72 KB
Volume: 5
Category: Article
ISSN: 1878-5077
DOI: 10.1186/1878-5085-5-S1-A42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MC13-0067 Association between Kras mutat

MC13-0067 Association between Kras mutation in circulating cell-free tumor DNA and clinical progression of colorectal cancer in patients receiving cetuximab

✍ Del Re, M.; Ulivi, P.; Belcari, F.; Passardi, A.; Zoli, W.; Amadori, D.; Danesi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Comparison of KRAS mutation analysis of

Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer

✍ Kuo, Yung-Bin; Chen, Jinn-Shiun; Fan, Chung-Wei; Li, Yi-Shuan; Chan, Err-Cheng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Detection of tumor mutant DNA in plasma

Detection of tumor mutant DNA in plasma of patient with colorectal cancer

✍ Ming Li; Wen-hui Wan; Jin Gu 📂 Article 📅 2002 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 263 KB

Postoperative Detection of Circulating T

Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients

✍ Galizia, Gennaro; Gemei, Marica; Orditura, Michele; Romano, Ciro; Zamboli, Anna; 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 324 KB

Detection of free-circulating tumor-asso

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis

✍ Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

## Abstract Tumor cells are characterized by specific genetic alterations. When such genetic alterations are identified in body fluid including plasma, regardless of the presence of detectable tumor cells, it shows the existence of free‐circulating tumor‐associated DNA. The objective of our study w

Detection of EGFR and KRAS mutations in

Detection of EGFR and KRAS mutations in circulating free DNA in patients with operable non small cell lung cancer (NSCLC)

✍ Board, R.; Shah, R.; Priest, L.; Bishop, P.; Ranson, M.; Hughes, A.N.; Dive, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB